FDA chief expresses concern over potential leadership and policy changes under Trump's second term.
FDA Commissioner Robert Califf expressed uncertainty about changes under President-elect Trump's second term, hinting at potential shifts in leadership and policy. Trump has promised a significant role for vaccine skeptic Robert F Kennedy Jr in public health decisions, which could disrupt the agency. Califf hopes that knowledgeable staff will remain to ensure public health welfare.
4 months ago
7 Articles
Further Reading
You have 12 free stories remaining this month. Subscribe anytime for unlimited access.